{"id":"NCT04085367","sponsor":"Galderma R&D","briefTitle":"Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face","officialTitle":"A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis (AK) of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-30","primaryCompletion":"2021-03-03","completion":"2021-04-07","firstPosted":"2019-09-11","resultsPosted":"2022-04-01","lastUpdate":"2022-04-01"},"enrollment":557,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratoses"],"interventions":[{"type":"DRUG","name":"MAL 16.8% cream","otherNames":["CD06809-41"]},{"type":"DRUG","name":"MAL Vehicle Cream","otherNames":[]}],"arms":[{"label":"MAL 16.8% Cream","type":"EXPERIMENTAL"},{"label":"MAL Vehicle Cream","type":"PLACEBO_COMPARATOR"}],"summary":"A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl aminolevulinate hydrochloride (MAL) 16.8% cream (CD06809-41) versus vehicle cream in the treatment of thin and moderately thick, non-hyperkeratotic, non-pigmented actinic keratosis of the face and scalp when using daylight photodynamic therapy (DL-PDT).","primaryOutcome":{"measure":"Percentage of Participants With Complete Response at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"MAL 16.8% Cream","deltaMin":25.3,"sd":null},{"arm":"MAL Vehicle Cream","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":60,"countries":["United States","Puerto Rico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":364},"commonTop":["Actinic keratosis","Application site pain","Application site erythema","Post procedural haemorrhage","Application site dermatitis"]}}